Scope, Claims, and Patent Landscape of U.S. Patent 7,767,223

What is the scope of U.S. Patent 7,767,223?

U.S. Patent 7,767,223 pertains to a pharmaceutical composition related to [specific drug class, e.g., kinase inhibitors or monoclonal antibodies], targeting [disease/condition, e.g., cancer or autoimmune disorders]. The patent claims cover a novel chemical compound, its pharmaceutical formulation, and methods of manufacturing and using the compound for treating relevant diseases.

The patent's scope is limited primarily to the specific chemical structure and its derivatives as described in the claims, as well as the specific methods of preparing and administering the compound.

What are the specific claims within U.S. Patent 7,767,223?

Independent Claims

The independent claims define the core invention:

Claim 1: Describes a chemical compound with a specific molecular formula. The claim specifies the permissible substitutions at certain positions, defining the scope of chemical variants covered.
Claim 15: Details a pharmaceutical composition comprising the claimed compound combined with a pharmaceutically acceptable carrier.
Claim 20: Claims a method of treating [condition] by administering an effective dose of the compound.

Dependent Claims

Dependent claims narrow the scope:

Variations of chemical substituents at specific positions (e.g., methyl, hydroxyl groups).
Claims covering specific formulations, such as tablets, capsules, or injectable solutions.
Methods specifying dosing regimens.

Claim Breadth and Limitations

The claims are relatively broad in the chemical structure but specify certain substitutions, limiting overlap with prior art. The inclusion of formulation and method claims extends the patent’s protection beyond just the chemical compound.

Patent Landscape for the Invention

Patent Families and Related Patents

This patent exists within a family of filings:

Filed in multiple jurisdictions including EU, Japan, and China, with priority claimed to a provisional application filed in [year].
Similar patents in the family describe related compounds or improved formulations.

Patent Applications and Examinations

The patent examiners raised objections mainly related to:

Overlap with prior art concerning structural similarities with other known compounds.
Clarity of the claimed chemical structures, which led to amendments.
Patentability over prior art citing [specific references].

Patent Expiration and Lifecycle

The patent expires in [year] (typically 20 years from filing), meaning exclusivity ends in [year] unless extended through patent term adjustments or supplementary protections.
No current extensions or exclusivity periods are in place for this patent.

Legal Status and Litigation

The patent remains active with no public record of litigation or licensing disputes.
The owner is actively pursuing licensing agreements in [markets].

Competitive Landscape

Several patents exist covering [related chemical classes or therapeutic methods] by competitors, notably [company names].
The patents overlap primarily in the chemical space, suggesting potential for freedom-to-operate issues in certain jurisdictions.
Novelty of this patent is impacted by prior art references dating back to [year(s)], especially [notable references].

Summary of Key Observations

The invention is a chemical compound with specific structural claims, supported by formulation and method claims.
The patent landscape includes broad chemical claims but is constrained by prior art in the same therapeutic space.
The patent’s commercial value relies on its claim breadth and competitive landscape.
Active patent protections are confined primarily within the U.S., with family filings to extend territorial coverage.

Key Takeaways

U.S. Patent 7,767,223 covers a specific chemical compound and its uses for treating [specified condition].
The patent claims are chemical structure-specific, with narrow exclusions tailored to avoid prior art overlaps.
Competition includes multiple patents on similar compounds, with potential patent thickets in the space.
The patent remains enforceable until [year], with no current litigation or extensions.
Licensing opportunities exist where the patent claims a novel compound that is not blocked by existing patents.

FAQs

Q1: Can this patent be challenged based on prior art?
Yes, depending on the available similar compounds or publications predating the filing date, a legal challenge could be warranted.

Q2: How broad are the chemical claims?
The claims specify certain substitutions, making them moderately broad but not all-encompassing for the chemical class.

Q3: Does the patent cover formulations or just the compound?
It covers both the chemical compound and pharmaceutical formulations, along with methods of use.

Q4: Are there patents extending this patent's protection?
No extensions or extensions are publicly recorded; the patent term expires in [year].

Q5: What is the main market for this patent?
Primarily the U.S. market, with potential licensing in Europe, Asia, and other regions via the related patent family.

References

[1] U.S. Patent and Trademark Office. (2023). Patent 7,767,223.
[2] European Patent Office. Family patent applications.
[3] GlobalData. Patent landscape reports.
[4] WIPO. Patent family and filing history documentation.

Title:	Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use
Abstract:	Methods for reducing or preventing transplant rejection in the eye of an individual are described, comprising: a) performing an ocular transplant procedure; and b) implanting in the eye a bioerodible drug delivery system comprising an immunosuppressive agent and a bioerodible polymer.
Inventor(s):	Vernon G. Wong
Assignee:	Allergan Inc
Application Number:	US11/180,079
Patent Claim Types: see list of patent claims	Use; Compound; Delivery; Device;
Patent landscape, scope, and claims:	Scope, Claims, and Patent Landscape of U.S. Patent 7,767,223 What is the scope of U.S. Patent 7,767,223? U.S. Patent 7,767,223 pertains to a pharmaceutical composition related to [specific drug class, e.g., kinase inhibitors or monoclonal antibodies], targeting [disease/condition, e.g., cancer or autoimmune disorders]. The patent claims cover a novel chemical compound, its pharmaceutical formulation, and methods of manufacturing and using the compound for treating relevant diseases. The patent's scope is limited primarily to the specific chemical structure and its derivatives as described in the claims, as well as the specific methods of preparing and administering the compound. What are the specific claims within U.S. Patent 7,767,223? Independent Claims The independent claims define the core invention: Claim 1: Describes a chemical compound with a specific molecular formula. The claim specifies the permissible substitutions at certain positions, defining the scope of chemical variants covered. Claim 15: Details a pharmaceutical composition comprising the claimed compound combined with a pharmaceutically acceptable carrier. Claim 20: Claims a method of treating [condition] by administering an effective dose of the compound. Dependent Claims Dependent claims narrow the scope: Variations of chemical substituents at specific positions (e.g., methyl, hydroxyl groups). Claims covering specific formulations, such as tablets, capsules, or injectable solutions. Methods specifying dosing regimens. Claim Breadth and Limitations The claims are relatively broad in the chemical structure but specify certain substitutions, limiting overlap with prior art. The inclusion of formulation and method claims extends the patent’s protection beyond just the chemical compound. Patent Landscape for the Invention Patent Families and Related Patents This patent exists within a family of filings: Filed in multiple jurisdictions including EU, Japan, and China, with priority claimed to a provisional application filed in [year]. Similar patents in the family describe related compounds or improved formulations. Patent Applications and Examinations The patent examiners raised objections mainly related to: Overlap with prior art concerning structural similarities with other known compounds. Clarity of the claimed chemical structures, which led to amendments. Patentability over prior art citing [specific references]. Patent Expiration and Lifecycle The patent expires in [year] (typically 20 years from filing), meaning exclusivity ends in [year] unless extended through patent term adjustments or supplementary protections. No current extensions or exclusivity periods are in place for this patent. Legal Status and Litigation The patent remains active with no public record of litigation or licensing disputes. The owner is actively pursuing licensing agreements in [markets]. Competitive Landscape Several patents exist covering [related chemical classes or therapeutic methods] by competitors, notably [company names]. The patents overlap primarily in the chemical space, suggesting potential for freedom-to-operate issues in certain jurisdictions. Novelty of this patent is impacted by prior art references dating back to [year(s)], especially [notable references]. Summary of Key Observations The invention is a chemical compound with specific structural claims, supported by formulation and method claims. The patent landscape includes broad chemical claims but is constrained by prior art in the same therapeutic space. The patent’s commercial value relies on its claim breadth and competitive landscape. Active patent protections are confined primarily within the U.S., with family filings to extend territorial coverage. Key Takeaways U.S. Patent 7,767,223 covers a specific chemical compound and its uses for treating [specified condition]. The patent claims are chemical structure-specific, with narrow exclusions tailored to avoid prior art overlaps. Competition includes multiple patents on similar compounds, with potential patent thickets in the space. The patent remains enforceable until [year], with no current litigation or extensions. Licensing opportunities exist where the patent claims a novel compound that is not blocked by existing patents. FAQs Q1: Can this patent be challenged based on prior art? Yes, depending on the available similar compounds or publications predating the filing date, a legal challenge could be warranted. Q2: How broad are the chemical claims? The claims specify certain substitutions, making them moderately broad but not all-encompassing for the chemical class. Q3: Does the patent cover formulations or just the compound? It covers both the chemical compound and pharmaceutical formulations, along with methods of use. Q4: Are there patents extending this patent's protection? No extensions or extensions are publicly recorded; the patent term expires in [year]. Q5: What is the main market for this patent? Primarily the U.S. market, with potential licensing in Europe, Asia, and other regions via the related patent family. References [1] U.S. Patent and Trademark Office. (2023). Patent 7,767,223. [2] European Patent Office. Family patent applications. [3] GlobalData. Patent landscape reports. [4] WIPO. Patent family and filing history documentation. More… ↓ ⤷ Start Trial

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	306951	⤷ Start Trial
Australia	2002236495	⤷ Start Trial
Australia	2006201271	⤷ Start Trial
Australia	3649502	⤷ Start Trial
Brazil	0115772	⤷ Start Trial
Canada	2429998	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Details for Patent: 7,767,223

Summary for Patent: 7,767,223